105 related articles for article (PubMed ID: 7962265)
1. Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir.
Leahy BJ; Christiansen KJ; Shellam G
J Virol Methods; 1994 Jun; 48(1):93-108. PubMed ID: 7962265
[TBL] [Abstract][Full Text] [Related]
2. A blinded comparison of two methods of viral susceptibility testing: plaque reduction assay versus microplate in situ ELISA.
Leahy BJ; Christiansen KJ; Collins P
J Virol Methods; 1996 Jan; 56(1):85-90. PubMed ID: 8690771
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates.
Safrin S; Palacios E; Leahy BJ
Antimicrob Agents Chemother; 1996 Apr; 40(4):1017-9. PubMed ID: 8849218
[TBL] [Abstract][Full Text] [Related]
4. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
[TBL] [Abstract][Full Text] [Related]
5. Simplified test for detecting the resistance of herpes simplex virus to acyclovir.
Agut H; Aubin JT; Ingrand D; Blanc S; Clayton AL; Chantler SM; Huraux JM
J Med Virol; 1990 Jul; 31(3):209-14. PubMed ID: 2167944
[TBL] [Abstract][Full Text] [Related]
6. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples.
Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810
[TBL] [Abstract][Full Text] [Related]
7. A rapid assay to screen for drug-resistant herpes simplex virus.
Tebas P; Scholl D; Jollick J; McHarg K; Arens M; Olivo PD
J Infect Dis; 1998 Jan; 177(1):217-20. PubMed ID: 9419192
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of herpes simplex virus susceptibility to acyclovir using an enzyme-linked immunosorbent assay.
André PM; Narbonne CH; Donnio PY; Ruffault A; Fauconnier B
Ann Inst Pasteur Virol; 1988; 139(2):185-95. PubMed ID: 2849962
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
10. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
11. Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents.
Myc A; Anderson MJ; Baker JR
J Virol Methods; 1999 Feb; 77(2):165-77. PubMed ID: 10092140
[TBL] [Abstract][Full Text] [Related]
12. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus.
Swierkosz EM; Scholl DR; Brown JL; Jollick JD; Gleaves CA
Antimicrob Agents Chemother; 1987 Oct; 31(10):1465-9. PubMed ID: 2829708
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of HSV strains from patients with genital herpes treated with various formulations of acyclovir.
Al-Hasani AM; Barton IG; Al-Omer LS; Kinghorn GR; Potter CW
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():113-9. PubMed ID: 3025151
[TBL] [Abstract][Full Text] [Related]
14. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
15. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
Safrin S; Elbeik T; Mills J
J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
[TBL] [Abstract][Full Text] [Related]
16. Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus.
Piret J; Goyette N; Boivin G
J Clin Microbiol; 2016 Aug; 54(8):2120-7. PubMed ID: 27252463
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
[TBL] [Abstract][Full Text] [Related]
18. Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers.
Rabalais GP; Levin MJ; Berkowitz FE
Antimicrob Agents Chemother; 1987 Jun; 31(6):946-8. PubMed ID: 3039912
[TBL] [Abstract][Full Text] [Related]
19. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
[TBL] [Abstract][Full Text] [Related]
20. Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.
Tebas P; Stabell EC; Olivo PD
Antimicrob Agents Chemother; 1995 Jun; 39(6):1287-91. PubMed ID: 7574517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
